vaccines

News

Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by E coli looks all but defunct after they abandon a phase 3 trial.

News

Despite a steep fall-off in sales of RSV vaccine Arexvy last year, GSK has raised its long-term sales forecast to £40 billion in 2031.

News

Bavarian Nordic is likely just weeks away from bringing the second chikungunya vaccine to the EU, and the first approved for use in adolescents.

News

Robert F Kennedy Jr's first confirmation hearing was a fractious affair, marked by tough questions about his prior anti-vaccine stance.

News

The NHS is dealing with a major rise in influenza cases, with the number of hospitalised patients quadrupling to around 5,000 ahead of the New Year.

News

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines.